TPG Growth, the middle market and growth equity platform of alternative asset firm TPG, has made a significant minority investment in AnovoRx Holdings (Anovo), a provider of specialty pharmacy services and customised treatment and support programs that address the unique needs of patients with certain complex and chronic diseases.
TPG Growth, the middle market and growth equity platform of alternative asset firm TPG, has made a significant minority investment in AnovoRx Holdings (Anovo), a provider of specialty pharmacy services and customised treatment and support programs that address the unique needs of patients with certain complex and chronic diseases.
Terms of the transaction have not been disclosed.
TPG is a global healthcare investor and has made numerous growth stage investments across the sector. Those transactions include BGB Group, Implantable Provider Group, Pharmeasy, Stelis Biopharma, and Vasaragen.
